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Summary. Cell-derived or extracellular vesicles, including
microparticles and exosomes, are abundantly present in
body fluids such as blood. Although such vesicles have
gained strong clinical and scientific interest, their detection
is difficult because many vesicles are extremely small with a
diameter of less than 100 nm, and, moreover, these vesicles
have a low refractive index and are heterogeneous in both
size and composition. In this review, we focus on the rela-
tively high throughput detection of vesicles in suspension
by flow cytometry, resistive pulse sensing, and nanoparticle
tracking analysis, and we will discuss their applicability
and limitations. Finally, we discuss four methods that are
not commercially available: Raman microspectroscopy,
micro nuclear magnetic resonance, small-angle X-ray scat-
tering (SAXS), and anomalous SAXS. These methods are
currently being explored to study vesicles and are likely to
offer novel information for future developments.
Keywords: exosomes, flow cytometry, microparticles,
raman spectroscopy, secretory vesicles.
Introduction
Cell-derived (extracellular) vesicles contain a phospholipid
bilayer and have diameters ranging from 50 nm to 5 lm
[1]. We will use the term ‘vesicles’ for all vesicles in
human body fluids and culture media because no consen-
sus exists on nomenclature and classification [1]. The sci-
entific and clinical interest in vesicles is increasing as they
contribute to health and disease processes and are poten-
tially useful as biomarkers and therapeutic agents.
The detection of vesicles is extremely challenging
because many vesicles have a diameter of less than
100 nm, have a low refractive index, are highly heteroge-
neous [2], and are sensitive to collection and handling
conditions [2–7]. Detection limitations have practical con-
sequences because methods such as flow cytometry have
been pushed to their limits, resulting not only in
improved detection but also in measurement of artefacts.
Vesicles have been studied extensively by electron
microscopy and functional (coagulation) assays since the
1950′s. Many investigators, including ourselves, have used
flow cytometry for the detection of vesicles since the
1990′s, but owing to the use of novel technologies, such
as nanoparticle tracking analysis (NTA), dynamic light
scattering (DLS), and resistive pulse sensing (RPS), we
have learned that many vesicles are too small to be
detected as single vesicles by flow cytometry. Since then,
the detection of vesicles has gained considerable interest,
and at present, a plethora of detection methods are being
explored and no gold standard exists for the detection of
vesicles. In parallel, attempts are being made to standard-
ize vesicle measurements and pre-analytical variables.
To illustrate the presence and dimensions of vesicles in
body fluids, Fig. 1A shows a size distribution of vesicles
in 1 mL platelet-free plasma after a single freeze/thaw
cycle, measured with NTA (Nanosight, Amesbury, UK).
The total number of particles/vesicles in this sample is
7.3 9 1010/mL, with a total surface area of 22 cm2
(Fig. 1B) and a total volume of 73 nL (Fig. 1C). Thus,
the total volume of the particle/vesicles is approximately
85-fold less than of leukocytes in 1 mL of blood, whereas
the total surface area is comparable.
Please also note that the size of vesicles is within a
range of easily detectable contaminants such as immune
complexes [8–10], calcium-phosphate microprecipitates
[11], liposomes and other particles [12], and fluorescent
antibody aggregates [13], which may introduce artefacts
in any of the techniques described in this review. For
example, we can erroneously reproduce the finding that
‘platelet-derived microparticles’ are present in synovial
fluid, but only when we do not remove the fluorescent
antibody aggregates before labeling of the vesicles [14,15].
The distributions shown in Fig. 1 may be affected by the
presence of contaminants. Nevertheless, Fig. 1 illustrates
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that vesicle measurements require instruments capable of
detecting the majority of such particles/vesicles in a large
size range.
In this manuscript, we focus on the detection of vesicles
free in suspension by commercially available instruments
capable of detection at relatively high throughput, that is,
time of analysis is minutes per sample under normal con-
ditions. Consequently, new detection methods requiring
binding of vesicles to a surface [16,17] are not discussed
and have been summarized elsewhere [2]. We will discuss
the limitations and shortcomings of each type of instru-
ment, and, in addition, we will present and discuss meth-
ods, which are not yet commercially available, but are
likely to offer new and relevant information and direc-
tions for future research.
Generally available techniques
Flow cytometry
Flow cytometry is well known for multiparameter measure-
ments of single cells at a flow rate of thousands per second.
For each cell, the forward and side scatter signals as well as
up to nine fluorescence signals can be detected. Flow
cytometry is the most commonly applied optical method to
detect vesicles in clinical samples because it is the most
widely available tool in clinical laboratories to investigate
single particles in body fluids [18]. The major challenge for
flow cytometry is the detection of single vesicles with a
diameter less than the present detection limit [19].
A schematic representation of a flow cytometer is
shown in Fig. 2. A hydrodynamically focused sample
stream passes through a laser beam. The intersection
between the laser beam and the sample stream is the
detection volume. When a cell in the sample stream
passes through the detection volume, the cell generates
scatter and fluorescence signals. A detector in line with
the laser beam detects forward scatter signal (FSC), and a
wide collection angle objective perpendicular to the laser
beam collects side scatter (SSC) and fluorescence. For
cells, which are large compared with the laser wavelength,
FSC is related to the cell diameter and SSC depends on
the presence of subcellular structures. For cells, FSC is
much larger than SSC, which means that the FSC detec-
tor requires, and typically has, a lower sensitivity than
the SSC detector. For vesicles small compared with the
laser wavelength, scatter is approximately equal in all
directions, and both FSC and SSC are primarily related
to vesicle diameter [19,20].
Scatter is determined by the diameter, refractive index,
absorption, and morphology of the vesicle, and the laser
wavelength [21]. Typically, the vesicle is assumed to be a
smooth sphere without absorption, allowing for the appli-
cation of Mie theory to determine the particle diameter
from a known laser wavelength and an assumed refractive
index. Fig. 3 shows how the diameter of vesicles, silica
beads, and polystyrene beads is related to the SSC signal
15
10
5
0
0
0
1
→
 V
o
lu
m
e 
(nL
)
→ Diameter (nm)
→
 S
ur
fa
ce
 a
re
a
 (m
m2
)
→
 N
um
be
r (
×1
09
/m
L)
0
50
In 1mL of blood
Leukocytes ≈ 2500 mm2
Vesicles / particles ≈ 1600 mm2
In 1mL of blood
Leukocytes ≈ 4500 nL
Vesicles / particles ≈      53 nL
100 200 300 400 500 600 700 800
A
B
C
Fig. 1. Properties of vesicles in plasma. (A) Distribution of particle/
vesicle sizes present in 1 mL plasma (histogram bin width 10 nm)
and a log-normal distribution that was least squares fit to the data
(red line). The log-normal fit was used to derive the distribution of
vesicle surface area (B) and total vesicle volume (C) per 10 nm bin.
For comparison, the total surface area/volume of 5 9 106 leukocytes
is shown in panels B and C.
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Fig. 2. Schematic representation of a flow cytometer The sample
flows from top to bottom and is surrounded by sheath fluid. The
laser intersects with the sample stream, generating scatter, and fluo-
rescence signals. Fluorescence and side scatter (SSC) are collected
perpendicular to laser beam and sample stream. Forward scatter
(FSC) is collected in line with the laser beam.
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in a FACSCalibur (BD biosciences, Franklin Lakes, NJ,
USA). In principle, this relation can be used to determine
the diameter of a particle using the SSC detector. For
example, a signal of 106 W on the SSC detector could
be generated by a 130 nm polystyrene bead, a 200 nm sil-
ica bead, or a single 240–580 nm vesicle. The latter range
is caused by uncertainty in the refractive index of vesicles,
with a small range in refractive index from 1.36 to 1.40
(Fig. 3). Recently, the refractive index range of vesicles
was estimated to range between 1.36 and 1.45 [22], which
would result in a size estimate of 190–1040 nm corre-
sponding to a signal of 106 mW in Fig. 3. The 5.5-fold
uncertainty in size caused by the uncertainty of refractive
indices is large compared with the relatively narrow size
distribution of vesicles [19].
In a typical flow cytometer, single polystyrene beads
with a diameter of 300–500 nm can be detected [23–25].
Novel commercial flow cytometers have a higher SSC
sensitivity, and the smallest detectable single polystyrene
bead is currently 100 nm [26–28], which corresponds to a
single vesicle with a diameter of 160–220 nm (Fig. 3,
range of refractive index cytosol 1.36–1.40). The relation-
ship between SSC and diameter depends on the optical
configuration of the instrument, including laser alignment,
which may change over time. In practice, however, the
relationship is not straightforward to obtain and no stan-
dardized method for converting SSC to size exists. There-
fore, this procedure is still being discussed [18,26,29,30].
An additional complication with the procedure of size
calibration using 500 and 900 nm polystyrene beads is
that they correspond to different vesicle sizes on different
flow cytometers. If we assume a refractive index of cyto-
sol of 1.38 [31], the 500–900 nm range from polystyrene
beads corresponds to a vesicle range of 1000–1750 nm
when detected using FSC on a Beckman Coulter FC500,
1250–2000 nm when detected using FSC on an Apogee
A40 [19], while it corresponds to a range of 2300–
4600 nm when detected using SSC on a Becton Dickinson
FACSCalibur.
Size determination independent of the refractive index
of vesicles can be achieved by applying resistive pulse
sensing (RPS), which can be combined with flow cytome-
try [32]. Nomenclature used for RPS in flow cytometry
includes ‘impedance based flow cytometry’ or the ‘Coulter
principle’. When a fluid containing vesicles flows through
an aperture, the electrical resistance of the aperture
increases when a vesicle is present. Although an appropri-
ate choice of aperture allows sizing of cells, vesicles, and
even molecules [33], a smaller aperture needed for smaller
vesicles also increases the risk of clogging. At this time,
no commercial flow cytometry systems are available with
RPS sensing apertures suitable for vesicle detection. The
Multisizer 3 (Beckman Coulter, Brea, CA, USA) can
detect vesicles that occupy 3% of the aperture diameter
[34]. With two symmetric RPS channels on a microfluidic
chip and a differential amplifier, this detection limit can
be reduced to 1% [34,35]. To reduce clogging, the effec-
tive sampling aperture can be reduced without reducing
the actual aperture by reducing the conductivity of the
sheath flow [36,37]. With the differential amplifier, or the
less conductive sheath fluid, a pore in the order of 5 lm
enables the sizing of single vesicles with a diameter of
50 nm to 5 lm.
Applicability and limitations The size distribution of ves-
icles (Fig. 1) shows that many vesicles in plasma have a
diameter < 100 nm. A flow cytometer that has a detection
limit of 200 nm polystyrene beads can detect individual
vesicles > 720 nm, which represents < 6% of the total
vesicle volume/surface area (Figs 1 and 3).
With the vast majority of vesicles being smaller than
the detection limit of current state of the art flow cytome-
ters, the question arises whether these ‘undetectable’ vesi-
cles contribute to the measurement. Two recent papers
demonstrate that the simultaneous presence of multiple
undetectable vesicles within the detection volume can pro-
duce a signal exceeding the detection threshold and is
interpreted as a single vesicle [19,38]. The detection vol-
ume of a FACSCalibur flow cytometer is approximately
50 pL [6], which is a suitable size for detection of cells.
At a typical vesicle concentration of 1010/mL plasma
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Fig. 3. Relationship between diameter and side scatter The diameter
of a vesicle can be derived from side scatter (SSC) when the refrac-
tive index (n) is known. SSC for polystyrene beads (PS, black mark-
ers) and silica beads (red markers) of known diameter and refractive
index was used to fit the SSC vs. diameter relationship (Mie theory,
solid lines). This was extrapolated for vesicles with a lipid membrane
with refractive index of 1.48 and a cytosol with refractive index of
1.36–1.40 (green band). A signal of 106 mW is generated by
130 nm PS, 200 nm silica, or 240–580 nm vesicles.
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[12,16], approximately 500 vesicles are simultaneously
present within the detection volume. If the combined SSC
from these vesicles exceeds the trigger threshold, for
example, because one of the vesicles is relatively large,
parameters are recorded for this group of vesicles as if
they are a single vesicle. This effect has been termed
‘swarm detection’ [19]. Swarm detection is easily recog-
nized by measuring a sample at different dilutions [38]
and allows detection of vesicles below the detection limit.
Importantly, the double-staining with fluorescently
labeled markers of vesicles for two or more antigens can
be due to the simultaneous presence of two vesicles within
the detection volume, each vesicle exposing one of the
antigens [19]. With bright fluorescent staining, triggering
on fluorescence may be less susceptible to artefacts,
because a single vesicle that is too small to be detected by
SSC may still be detectable by its fluorescence [38].
New developments Recently, the feasibility of fluorescent
detection of vesicles stained with the membrane interca-
lating dye PKH67 was demonstrated [39,40]. The flow cy-
tometer optical configuration was improved by installing
a 200 mW 488 nm laser, a wide-angle FSC detector and a
high-performance photomultiplier tube. These changes
allow detection of 100 nm polystyrene beads in FSC,
which has an improved size discrimination compared with
SSC [39]. The staining with PKH67 was followed by
removal of unbound dye as well as dye aggregates in a
sucrose density gradient. The PKH67 staining can be
combined with fluorescent antibody labeling. As the total
procedure takes up to 24 h [39], it is an exemplary flow
cytometry protocol but in its present form too laborious
for routine use. Implementation of RPS, wide-angle FSC,
high-performance photon multiplier tubes, and increased
irradiance will lead to further improvements of flow
cytometry for vesicle analysis.
Dynamic light scattering
Dynamic light scattering (DLS), also known as photon
correlation spectroscopy or quasi elastic light scattering,
determines the differential size distribution of particles
ranging in diameter between 1 nm and 6 lm [41,42]. The
sample is illuminated with a laser beam, and therefore, all
vesicles present in the beam will scatter light. The size dis-
tribution of these vesicles is obtained by measuring the
intensity fluctuations of the scattered light, followed by
applying a mathematical model derived from Brownian
motion and light scattering theory. The absolute concen-
tration of vesicles cannot be determined with DLS
because the mean signal amplitude depends on the diame-
ter, concentration, and refractive index of the vesicles.
Many commercial DLS instruments can also determine
the zeta potential, which is the electric potential difference
between the stationary layer of ions that is bound to the
vesicle and the medium.
Applicability and limitations In general, commercial DLS
instruments are practical in use. A measurement is typi-
cally performed within 1 min and requires sample volumes
as low as 20 lL. Accurate size distributions are expected
for monodisperse samples, that is, samples containing vesi-
cles of one particular size [43–45]. However, size distribu-
tions of polydisperse samples, such as vesicles in human
plasma, are less exact and require foreknowledge of the
sample to apply the most suitable mathematical model
[43,44]. For example, it is expected that size distributions
of polydisperse samples are biased toward small numbers
of large particles [44,45], such as platelets and other con-
taminants, because such particles scatter light more effi-
ciently than small vesicles. Therefore, DLS typically
obtains a more than twofold increase in the median diame-
ter of vesicles from plasma compared with other novel
techniques [6,12,16,46,47]. We conclude that DLS requires
careful data interpretation and may be a useful method
provided that the shape of the size distribution is known.
Resistive pulse sensing
Resistive pulse sensing (RPS) determines the absolute size
distribution of vesicles in suspension ranging in diameter
between ~50 nm and 10 lm by utilizing the Coulter prin-
ciple [48]. Resistive pulse sensors capable of measuring
smaller particles do exist [49], but such instruments are
very specialized. This text mainly focuses on a commercial
instrument named qNano (Izon Science Ltd, Christ-
church, New Zealand). Fig. 4A shows a schematic repre-
sentation of RPS, which consists of two fluid cells divided
by a non-conductive membrane. An electrical current
flows through a single pore in the membrane with a diam-
eter typically < 1 lm. Fig. 4B shows the current vs. time
when two vesicles from plasma successively pass through
the pore. The relative change in current is approximately
proportional to the volume of the vesicle and is calibrated
with beads of known diameter, a procedure that has been
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Fig. 4. Resistive pulse sensing. (A) Schematic representation of resis-
tive pulse sensing (RPS). The instrument consists of two fluid cells
divided by an insulating membrane containing a single pore. In each
fluid cell, an electrode is immersed to drive an ionic current through
the pore. (B) Current I vs. time for vesicles from plasma diluted 1:10
with PBS as measured by RPS (Izon qNano, Christchurch, New
Zealand). The two downward spikes DI are due to single vesicles
successively passing through the pore.
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verified using liposomes of known diameter (personal
communication, Izon Science Ltd). The sample volume
can be as low as 10 lL. By applying a pressure difference
between the fluid cells, pressure-driven flow dominates the
flow caused by electro-osmosis, electrophoresis, and diffu-
sion. The count rate is related to the concentration of ves-
icles using beads of known concentration [50].
Applicability and limitations Because the relative change
in current is proportional to the volume of the particle,
RPS can accurately determine the diameter of single par-
ticles. For example, we have sized 102 nm and 203 nm
NIST traceable polystyrene beads with an accuracy of
2% (data not shown). The size range that can be detected
is bound by the pore size at the upper limit and by the
smallest detectable resistance change at the lower limit,
which is approximately 20% of the pore diameter. For
example, a pore with a diameter of 400 nm is capable of
sizing vesicles ranging from ~80 to < 400 nm in diameter.
Flexible pores with adjustable pore sizes can be used to
increase the detection range.
A practical limitation of measuring biological samples
with RPS is pore clogging. The pore may get clogged due
to the accumulation of high molecular weight proteins
such as fibrinogen or von Willebrand Factor, or due to
particles larger than the pore, for example, apoptotic
blebs, small cells, and aggregates of vesicles or calibration
beads. It should be mentioned that the calibration beads
may form aggregates soon after dilution in PBS. If pore
clogging occurs, the measurement has to be paused for
pore unclogging. Both unclogging and contaminants such
as proteins sticking to the pore may alter the dimensions
of the sensing zone. Consequently, the calibration mea-
surement should be verified. Sample preparation to
remove vesicles larger than the pore and to reduce the
concentration of proteins is therefore critical.
From our experience, mainly due to pore clogging, the
measurement time ranges from 30 min to 1 h per biologi-
cal sample, making the qNano a research tool rather than
a tool suitable for clinical routine analysis.
New developments To automatically clean a clogged
pore, a resistive pulse sensor with integrated ultrasound
transducer is in development (personal communication,
Izon Science Ltd). While this is a promising development
for cleaning pores, careful testing is needed because soni-
cation may cause breakdown of vesicles.
Recently, the dependency of the resistance of the pore
on the particle position, particle size, and the dimensions
of the pore was analytically described [51], allowing deter-
mination of the zeta potential of single particles.
Nanoparticle tracking analysis
Nanoparticle tracking analysis (NTA), commercialized by
Nanosight Ltd (Amesbury, UK), measures the absolute
size distribution of vesicles ranging from ~50 nm to 1 lm
in diameter. Vesicles in suspension are illuminated by a
laser beam and scatter light or exhibit fluorescence. A
dark-field microscope is used to determine the position of
single vesicles, which are continuously moving due to
Brownian motion. For each vesicle, the movements are
tracked and the mean squared velocity is calculated.
Because the mean squared velocity of the Brownian
motion depends on the particle diameter, an absolute size
distribution of vesicles in suspension can be obtained
after the system has been calibrated with beads of known
concentration [12]. NTA can determine the zeta potential
by applying an electric field across the suspension and
measuring the velocity of single vesicles due to electro-
phoresis [52]. With fluorescent labeling, NTA can be used
to determine the size of a subgroup of vesicles [53].
Applicability and limitations With a typical measurement
time of several minutes, NTA is convenient to use. The
visualization of samples provides real-time feedback on
the aggregation of particles and on the possible presence
of cells after vesicle isolation. Furthermore, NTA is capa-
ble of detecting single vesicles with a diameter as low as
50 nm based on light scattering and detecting even smaller
vesicles if labeled with at least a single quantum dot [12].
Uncertainty in the position determination and the lin-
ear relationship between the reciprocal diameter of a par-
ticle and its diffusion coefficient lead to broadening of the
obtained size distribution. Consequently, two populations
can only be resolved if their particle diameters differ by
at least 1.5-fold. In addition, the accuracy of the determi-
nation of the concentration of vesicles or a mixture of
beads with different diameters is strongly affected by their
size and refractive index, the uniformity and power of
illumination, and the camera settings. For example, in a
heterogeneous mixture of polystyrene beads (Thermo
Fisher Scientific, Waltham, MA, USA), the concentration
of 596 nm beads is overestimated more than 7-fold by
NTA (data not shown). For vesicles, this problem can be
contained by calibrating the instrument with 100 nm sil-
ica beads of known concentration [54], selecting a vesicle
concentration between 108 and 109 vesicles mL1, and
optimizing the camera gain [55]. When studying vesicles
in biological samples, it is recommended to perform two
measurements. First, the sample is undiluted and a low
camera gain is used to track the relatively low concentra-
tion of large vesicles. Second, the sample is diluted and
the most sensitive camera setting is used to track the rela-
tively high concentration of small vesicles.
NTA generates 1–2 GB of video data per measurement,
which means that data backup and handling require con-
siderable time and storage capacity. The generated video
data require sophisticated data processing, involving mul-
tiple operations and variables. Although there is a ten-
dency toward the automatic determination of these
variables, substantial operator skill is required.
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New developments An instrument that supports dual
labeling by utilizing two fluorescence channels is under
development, as well as high throughput solutions, such
as an autosampler and an extension capable of automati-
cally diluting samples (personal communication Nano-
sight Ltd).
Beyond state of the art: detection of vesicles by
specialized techniques
Raman microspectroscopy
Raman spectroscopy is based on the detection of inelastic
light scattering and is used to study the structure and
chemical composition of macromolecules inside single liv-
ing cells [56]. The sample is illuminated by monochro-
matic laser light. When the light is inelastically scattered
by the sample, the wavelength shifts due to an energy
gain or loss associated with molecular vibrations in the
sample. Because this wavelength shift is molecule specific,
Raman spectroscopy allows label-free examination. With
Raman microspectroscopy, the probe volume is typically
< 1 lm3, which overlaps with the dimension of vesicles.
Fig. 5 shows the Raman spectrum of a single vesicle iso-
lated from an erythrocyte concentrate by differential cen-
trifugation. This spectrum was obtained using a confocal
Raman microspectrometer, in which a 647-nm laser with
a power of 100 mW was focused on a probe volume of
0.3 lm3 [57]. Due to the high irradiance, the vesicle was
optically trapped in the laser beam. The peaks in the
spectrum are specific to the chemical bonds and symmetry
of the molecules. Because the amplitude of the signal is
linearly proportional to the number of molecules, Raman
microspectroscopy is a quantitative technique. Recently,
Raman microspectroscopy was applied to study vesicles
of Dictyostelium discoideum, a convenient model to study
eukaryotic vesicles [58]. Without labeling, at least two dif-
ferent types of vesicles were identified, illustrating that
Raman microspectroscopy allows label-free distinction
between single vesicles of different composition.
Applicability and limitations Raman microspectroscopy
is a relatively expensive and specialized method with lim-
ited availability. In addition, a measurement takes consid-
erable time, because trapping is a stochastic process and
because the intensity of Raman scattering is weak com-
pared with Rayleigh scattering. Consequently, acquisition
times in the order of seconds per vesicle are required.
Thus, with the current state of the art, obtaining Raman
spectra from 1000 vesicles would take hours.
New developments To obtain simultaneous information
on the size, concentration, and chemical composition of
single vesicles in suspension without fluorescence antibody
labeling, we will combine Raman microspectroscopy with
RPS (qNano). The sample stream in the qNano will force
vesicles through the focused laser beam to reduce mea-
surement time.
Micro NMR
Nuclear magnetic resonance (NMR) can be used to mea-
sure the magnetic susceptibility of a sample, that is, the
degree of sample magnetization in response to an applied
magnetic field. In general, biological samples have negligi-
ble magnetic susceptibility [59], but using magnetic nano-
particles conjugated to an antibody, the presence of an
antigen exposed on a vesicle can be detected. The minia-
turized micro nuclear magnetic resonance (lNMR) sys-
tem [60] is a lab-on-a-chip NMR device capable of
measuring the large contrast in magnetic susceptibility
between biological samples and magnetic nanoparticles.
Vesicles with a diameter of 50–150 nm are loaded into
multiple parallel chambers, each chamber containing a
50 nm pore size filter to prevent the vesicles from leaving
the chamber while allowing reagents to pass through the
chamber. Each chamber is labeled with a different anti-
body conjugated to 38 nm ferrite nanoparticles [61]. The
number of vesicles present in a chamber is estimated by
labeling vesicles in one of the chambers with an antibody
directed against CD63, a tetraspanin exposed on many
vesicles. The magnetic susceptibility detected in the paral-
lel sample chambers is normalized for the CD63 signal to
account for variations in the number of vesicles in each
chamber. The lNMR system detects the presence of mag-
netic nanoparticles in the sample chamber with great sen-
sitivity. For example, the CD63 signal from 104 vesicles
could be detected, which is claimed to be a 1000-fold
more sensitive than ELISA. The sample size is 1 lL per
chamber and the measurement time approximately 1 h.
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Fig. 5. Raman spectrum of a single erythrocyte-derived vesicle The
Raman spectrum of a single erythrocyte vesicle is shown in suspen-
sion after subtraction of the background spectrum of the medium.
The peaks reveal specific chemical bonds, which are present in this
vesicle. For instance, the peak at 1654 cm1 is characteristic for
Amide I, the peak at 1440 cm1 is characteristic for methylene (C-
H2) bending, and the peak at 2947 cm
1 is characteristic for hydro-
carbon (C–H) stretching.
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Applicability and limitations The lNMR has been
applied to detect glioblastome multiforme (GBM) vesicles
in plasma of mice and humans [60]. lNMR provides no
information on single vesicles. Nevertheless, the high sen-
sitivity of this method beholds great promise to detect
rare vesicles, such as tumor-derived vesicles in plasma
samples. For example, in GBM, vesicles may be a new
serological biomarker in a field where the currently avail-
able biomarkers are insensitive and expensive to measure
[60]. The number of different antigens that can be
detected can be expanded by loading and labeling more
sample chambers. Changing the filter pore sizes used for
sample preparation may allow biochemical characteriza-
tion of vesicles of different sizes.
Small-angle X-ray scattering (SAXS)
The small-angle X-ray scattering method is based on the
elastic scattering of X-ray photons at low angles. In con-
trast to protein crystallography, where the atomic struc-
ture of macromolecules is determined by collecting the
scattering pattern at wide angles, SAXS can provide
structural information on nanomaterials, for example, the
bilayer thickness of vesicles, in the 1 nm to 100 nm size
range. For sufficiently monodisperse nanoparticles, a
traceable size determination is possible [62,63]. SAXS
measurements require monochromatic X-ray with a wave-
length below 1 nm, which is perfectly suited to probe
nanomaterials. The forward scattered radiation from the
sample is recorded at small angles (typically up to about
3°) with a large area pixel detector placed at variable dis-
tance (typically 1 m to 4 m) from the sample. The one-
dimensional scattering curves as function of the scattering
angle are obtained by radial averaging of the two-dimen-
sional scattering pattern. The momentum transfer
depends on the scattering angle and wavelength, and pro-
vides information for dimensional characterization.
SAXS was already applied to describe the organization
of the lipid bilayer of various vesicles of synthetic and
natural origin [64–67], for example, Castorph et al. stud-
ied the structure of synaptic vesicles using SAXS and
obtained detailed information on size, density, and com-
position [67]. Because extracellular vesicles are enclosed
by a phospholipid bilayer membrane, SAXS can provide
detailed information on their phospholipid bilayer struc-
ture and embedded transmembrane proteins, which are
both in the nm range. In the case of objects such as vesi-
cles with overall diameter below 100 nm, the scattering of
the whole vesicle appears at low momentum transfer,
enabling the characterization of the vesicle size and shape.
These features can be demonstrated for synthetic phos-
pholipid vesicles, which are commonly used as model sys-
tems for biological membranes and as drug delivery
vehicles. The scattered intensity of a liposome system with
a diameter of 100 nm is shown in Fig. 6.
Applicability and limitations While SAXS has been
applied in soft matter science, two main limitations have to
be considered. The scattered intensity relates to the sixth
power of the radius in the case of spherical particles, caus-
ing large differences in the scattering signal from particles
with different sizes. As a consequence, the scattering from
samples containing vesicles with large differences in diame-
ter may lead to ambiguous determination of the size distri-
bution. As small-angle scattering results from electron
density discontinuities, the second limitation is the decrease
in the scattered intensity with decreasing (electron) density
contrast. Therefore, SAXS characterization of biological
materials that have a low electron density contrast relative
to the aqueous media requires very intense monochromatic
X-rays, which are usually available only at synchrotron
radiation facilities. Fig. 7A shows the electron storage ring
BESSY II with 250 meter circumference in Berlin, together
with the laboratory of PTB [68]. Beamline 2a in this figure
is the 40 meter long four-crystal monochromator beamline.
The SAXS set-up of Helmholtz-Zentrum Berlin is installed
at this beamline as shown in Fig. 7B. The monochroma-
tized and collimated X-ray beam interacts with the sample
placed in a vacuum chamber.
Anomalous Small-angle X-ray scattering (ASAXS)
Biological samples exhibit complex small-angle scattering
curves due to their multicomponent nature and hierarchical
structural characteristics. Identifying each scattering con-
tribution is the main challenge in the interpretation of
SAXS curve of samples such as vesicles. Separation of the
scattering contributions of the different constituents of this
complex system can be achieved using anomalous small-
angle X-ray scattering (ASAXS). Because every chemical
element has characteristic X-ray absorption edges, the pres-
ence of each element can be detected by recording scatter-
ing curves at appropriate wavelengths. In case of vesicles,
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Fig. 6. Scattered intensity of phospholipid vesicles by SAXS The
scattering intensity curve of 100 nm phospholipid vesicles provides
information about the size (low q) and bilayer thickness (high q) of
the vesicles. The relevant physical quantity for the dimensional char-
acterization is the momentum transfer q, which is related to and
wavelength k and scattering angle h by q = 4p/k sin h.
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ASAXS can identify the contribution from proteins (sul-
fur), phospholipids, and nucleic acids (phosphorus). For
example, the distribution of proteins between the inner and
outer side of the phospholipid bilayer can be determined,
as well as the thickness of the bilayer. Because the absorp-
tion edges of relevant elements of vesicles are at photon
energies below 3 keV where the penetration length of X-
ray is limited, the commonly used glass capillaries have to
be replaced by a dedicated sample cell with thin (< 1 lm)
silicon nitride windows. The sample cell and the detector
have to be placed in vacuum. A vacuum-compatible large
area X-ray detector has become only recently available and
will be used to study vesicles present in human body fluids
in the Metves project (www.metves.eu) [69].
Discussion
Vesicles have become firmly established entities, a fact
illustrated by founding of the International Society of
Extracelluar Vesicles (www.isev.org). Only recently it has
become apparent, however, by application of novel com-
mercially available technologies such as NTA and RPS,
that many vesicles are extremely small with a diameter of
less than 100 nm. The straightforward detection of such
vesicles is hampered by their small size, high concentra-
tion, low refractive index, and heterogeneity in size, com-
position, and morphology.
In this review, we have shown that application of com-
mercially available methods for vesicle detection requires
background knowledge of the underlying principles of
such methods, so that obtained results can be appropri-
ately interpreted. Also, measurement results on vesicles
by application of such methods have been insufficiently
compared with each other, and at present, standard popu-
lations of vesicles are being studied using transmission
electron microscopy, flow cytometry (BD FACSCalibur,
Apogee A50-micro), NTA (Nanosight NS500, Nanosight
LM-10), and RPS (Izon qNano, personal communica-
tion). We hope to learn from such studies what the capa-
bilities and limitations are of the methods [2] and what
the true concentration and diameter are of vesicles in bio-
logical fluids.
We have also shown that exciting attempts are now
being made to explore the cutting edge of physical and
biochemical know-how to improve the detection of vesi-
cles. Some of the methods, such as SAXS, can provide
the absolute size or size distribution of vesicles in suspen-
sion, whereas other methods, such as Raman microspec-
troscopy, have the potential to obtain biochemical
information, such as cellular origin, on the level of single
vesicles directly in suspension without labeling.
For the vesicle field to leap forward, the detection lim-
its of existing technologies need to be pushed further or
the detection limits need to be improved by combining
technologies and developing new technologies. With more
sensitive technology, we expect to gain a growing insight
into the composition, biological and clinical relevance of
vesicles in health and disease.
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Fig. 7. Measuring vesicles by Small-Angle X-ray Scattering A. The layout of the PTB laboratory at the BESSY II synchrotron radiation facil-
ity in Berlin (Germany). The ring circumference is 250 m. B. The generated X-ray photons pass the four-crystal monochromator beamline.
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